AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,090.00
-70.00 (-0.98%)
May 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Product Sales (ODM)
209.82M
Log In
Log In
Log In
Log In
Product Sales (General)
61.74M
Log In
Log In
Log In
Log In
Reagent
52.31M
Log In
Log In
Log In
Log In
Reagent Growth
8.19%
Log In
Log In
Log In
Log In
Services
-
Log In
Log In
Log In
Log In
Services Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
South Korea
323.87M
Log In
Log In
Log In
Log In
South Korea Growth
569.80%
Log In
Log In
Log In
Log In